The Filings Report

IQVIA Holdings Inc.

IQVNYSECIK 1478242Healthcare / Diagnostics & Researchfiscal year ends December60 quarters since 2011

Revenue, Q3 FY2026
$4.4B
+8.0% on Q3 FY2025
Net income
$350M
+5.7% on Q3 FY2025
Free cash flow
$667M
−13.6% on Q3 FY2025
Diluted EPS
$2.10
+8.8% on Q3 FY2025
Revenue, TTM
$17.3B
trailing four quarters
Net margin, TTM
8.1%
net income $1.4B
Free cash flow, TTM
$2.1B
$2.7B less $657M capex
Cash and equivalents
$2.2B
long-term debt $14.8B, Sep 30, 2026
Shares, 12-month change
−3.2%
165M shares, Sep 30, 2026
Buybacks, TTM
$1.2B
2.6% of market value
Dividends, TTM
—
no yield
Market value
$44.1B
at the close, buybacks

Latest quarter Q3 FY2026, filed October 27, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, IQVIA Holdings Inc. reported revenue of $4.4B, +8.0% on Q3 FY2025, and net income of $350M (+5.7%). Operating margin was 12.9%. Free cash flow, operating cash flow less capital expenditures, was $667M ($825M less $158M). Diluted earnings per share were $2.10.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of October 27, 2026.

Revenue and net incomeRevenueNet income
$0$2B$4B$6BQ4'22, Revenue: $3.7BQ4'22, Net income: $227MQ4'22Q1'23, Revenue: $3.7BQ1'23, Net income: $289MQ1'23Q2'23, Revenue: $3.7BQ2'23, Net income: $297MQ2'23Q3'23, Revenue: $3.7BQ3'23, Net income: $303MQ3'23Q4'23, Revenue: $3.9BQ4'23, Net income: $469MQ4'23Q1'24, Revenue: $3.7BQ1'24, Net income: $288MQ1'24Q2'24, Revenue: $3.8BQ2'24, Net income: $363MQ2'24Q3'24, Revenue: $3.9BQ3'24, Net income: $285MQ3'24Q4'24, Revenue: $4.0BQ4'24, Net income: $437MQ4'24Q1'25, Revenue: $3.8BQ1'25, Net income: $249MQ1'25Q2'25, Revenue: $4.0BQ2'25, Net income: $266MQ2'25Q3'25, Revenue: $4.1BQ3'25, Net income: $331MQ3'25Q4'25, Revenue: $4.4BQ4'25, Net income: $514MQ4'25Q1'26, Revenue: $4.2BQ1'26, Net income: $274MQ1'26Q2'26, Revenue: $4.4BQ2'26, Net income: $256MQ2'26Q3'26, Revenue: $4.4BQ3'26, Net income: $350MQ3'26$0$2B$4B$6BQ4'22, Revenue: $3.7BQ4'22, Net income: $227MQ1'23, Revenue: $3.7BQ1'23, Net income: $289MQ1'23Q2'23, Revenue: $3.7BQ2'23, Net income: $297MQ3'23, Revenue: $3.7BQ3'23, Net income: $303MQ3'23Q4'23, Revenue: $3.9BQ4'23, Net income: $469MQ1'24, Revenue: $3.7BQ1'24, Net income: $288MQ1'24Q2'24, Revenue: $3.8BQ2'24, Net income: $363MQ3'24, Revenue: $3.9BQ3'24, Net income: $285MQ3'24Q4'24, Revenue: $4.0BQ4'24, Net income: $437MQ1'25, Revenue: $3.8BQ1'25, Net income: $249MQ1'25Q2'25, Revenue: $4.0BQ2'25, Net income: $266MQ3'25, Revenue: $4.1BQ3'25, Net income: $331MQ3'25Q4'25, Revenue: $4.4BQ4'25, Net income: $514MQ1'26, Revenue: $4.2BQ1'26, Net income: $274MQ1'26Q2'26, Revenue: $4.4BQ2'26, Net income: $256MQ3'26, Revenue: $4.4BQ3'26, Net income: $350MQ3'26

Net income losses drawn in red.

Free cash flow
$0$200M$400M$600M$800MQ4'22, Free cash flow: $389MQ4'22Q1'23, Free cash flow: $253MQ1'23Q2'23, Free cash flow: $242MQ2'23Q3'23, Free cash flow: $437MQ3'23Q4'23, Free cash flow: $568MQ4'23Q1'24, Free cash flow: $377MQ1'24Q2'24, Free cash flow: $445MQ2'24Q3'24, Free cash flow: $571MQ3'24Q4'24, Free cash flow: $721MQ4'24Q1'25, Free cash flow: $426MQ1'25Q2'25, Free cash flow: $292MQ2'25Q3'25, Free cash flow: $772MQ3'25Q4'25, Free cash flow: $561MQ4'25Q1'26, Free cash flow: $491MQ1'26Q2'26, Free cash flow: $360MQ2'26Q3'26, Free cash flow: $667MQ3'26$0$200M$400M$600M$800MQ4'22, Free cash flow: $389MQ1'23, Free cash flow: $253MQ1'23Q2'23, Free cash flow: $242MQ3'23, Free cash flow: $437MQ3'23Q4'23, Free cash flow: $568MQ1'24, Free cash flow: $377MQ1'24Q2'24, Free cash flow: $445MQ3'24, Free cash flow: $571MQ3'24Q4'24, Free cash flow: $721MQ1'25, Free cash flow: $426MQ1'25Q2'25, Free cash flow: $292MQ3'25, Free cash flow: $772MQ3'25Q4'25, Free cash flow: $561MQ1'26, Free cash flow: $491MQ1'26Q2'26, Free cash flow: $360MQ3'26, Free cash flow: $667MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15BQ4'22, Cash and equivalents: $1.2BQ4'22, Long-term debt: $12.6BQ4'22Q1'23, Cash and equivalents: $1.5BQ1'23, Long-term debt: $11.8BQ1'23Q2'23, Cash and equivalents: $1.4BQ2'23, Long-term debt: $12.4BQ2'23Q3'23, Cash and equivalents: $1.2BQ3'23, Long-term debt: $12.3BQ3'23Q4'23, Cash and equivalents: $1.4BQ4'23, Long-term debt: $13.0BQ4'23Q1'24, Cash and equivalents: $1.4BQ1'24, Long-term debt: $12.8BQ1'24Q2'24, Cash and equivalents: $1.5BQ2'24, Long-term debt: $12.1BQ2'24Q3'24, Cash and equivalents: $1.6BQ3'24, Long-term debt: $12.3BQ3'24Q4'24, Cash and equivalents: $1.7BQ4'24, Long-term debt: $12.8BQ4'24Q1'25, Cash and equivalents: $1.7BQ1'25, Long-term debt: $13.1BQ1'25Q2'25, Cash and equivalents: $2.0BQ2'25, Long-term debt: $14.2BQ2'25Q3'25, Cash and equivalents: $1.8BQ3'25, Long-term debt: $12.8BQ3'25Q4'25, Cash and equivalents: $2.0BQ4'25, Long-term debt: $13.9BQ4'25Q1'26, Cash and equivalents: $1.9BQ1'26, Long-term debt: $14.0BQ1'26Q2'26, Cash and equivalents: $1.9BQ2'26, Long-term debt: $13.7BQ2'26Q3'26, Cash and equivalents: $2.2BQ3'26, Long-term debt: $14.8BQ3'26$0$5B$10B$15BQ4'22, Cash and equivalents: $1.2BQ4'22, Long-term debt: $12.6BQ1'23, Cash and equivalents: $1.5BQ1'23, Long-term debt: $11.8BQ1'23Q2'23, Cash and equivalents: $1.4BQ2'23, Long-term debt: $12.4BQ3'23, Cash and equivalents: $1.2BQ3'23, Long-term debt: $12.3BQ3'23Q4'23, Cash and equivalents: $1.4BQ4'23, Long-term debt: $13.0BQ1'24, Cash and equivalents: $1.4BQ1'24, Long-term debt: $12.8BQ1'24Q2'24, Cash and equivalents: $1.5BQ2'24, Long-term debt: $12.1BQ3'24, Cash and equivalents: $1.6BQ3'24, Long-term debt: $12.3BQ3'24Q4'24, Cash and equivalents: $1.7BQ4'24, Long-term debt: $12.8BQ1'25, Cash and equivalents: $1.7BQ1'25, Long-term debt: $13.1BQ1'25Q2'25, Cash and equivalents: $2.0BQ2'25, Long-term debt: $14.2BQ3'25, Cash and equivalents: $1.8BQ3'25, Long-term debt: $12.8BQ3'25Q4'25, Cash and equivalents: $2.0BQ4'25, Long-term debt: $13.9BQ1'26, Cash and equivalents: $1.9BQ1'26, Long-term debt: $14.0BQ1'26Q2'26, Cash and equivalents: $1.9BQ2'26, Long-term debt: $13.7BQ3'26, Cash and equivalents: $2.2BQ3'26, Long-term debt: $14.8BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.

IQVIA Holdings Inc. income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 27, 2026Q2 FY2026ended Jun 30, 2026filed Jul 28, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Jul 22, 2025Q1 FY2025ended Mar 31, 2025filed May 6, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue4,4284,3684,1514,3644,1004,0173,8293,958+8.0%
Cost of revenue—————————
Gross profit—————————
Research and development—————————
Selling, general and administrative569574502468514509508453+10.7%
Operating income572506514627553506496626+3.4%
Other income (expense)5(12)(4)9431(11)(15)78−83.9%
Pretax income386301328537408323323544−5.4%
Income tax766059597656611120.0%
Net income350256274514331266249437+5.7%
Diluted EPS ($)2.101.531.61—1.931.541.40—+8.8%
Diluted shares (millions)167167170—172173177——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.

IQVIA Holdings Inc. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 27, 2026Q2 FY2026ended Jun 30, 2026filed Jul 28, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Jul 22, 2025Q1 FY2025ended Mar 31, 2025filed May 6, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents2,2491,9091,9471,9801,8142,0391,7401,702+24.0%
Short-term investments173171156161158149136141+9.5%
Total current assets6,4516,2266,2206,2495,9796,3455,9115,829+7.9%
Total assets30,47429,88129,67529,94428,72728,63227,32226,899+6.1%
Total current liabilities7,7778,8158,3298,3388,5087,5727,1796,957−8.6%
Long-term debt14,82313,70513,98913,88412,79314,17713,10812,838+15.9%
Total liabilities23,68323,58023,32623,31422,43922,84621,33720,832+5.5%
Stockholders’ equity6,6606,1716,2216,5036,1605,7785,9776,067+8.1%
Shares outstanding (millions)165165167170170170173176—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed October 27, 2026.

IQVIA Holdings Inc. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Oct 27, 2026Q2 FY2026ended Jun 30, 2026filed Jul 28, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Oct 28, 2025Q2 FY2025ended Jun 30, 2025filed Jul 22, 2025Q1 FY2025ended Mar 31, 2025filed May 6, 2025Q4 FY2024ended Dec 31, 2024filed Feb 13, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow825558618735908443568885−9.1%
Capital expenditures158198127174136151142164+16.2%
Free cash flow (CFO − capex)667360491561772292426721−13.6%
Depreciation and amortization321292288317286276265303+12.2%
Share repurchases039855221206573751,150—
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 17, 2026.

Income statement

IQVIA Holdings Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 15, 2023FY2021ended Dec 31, 2021filed Feb 16, 2022FY2020ended Dec 31, 2020filed Feb 12, 2021FY2019ended Dec 31, 2019filed Feb 18, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Feb 16, 2018FY2016ended Dec 31, 2016filed Feb 16, 2017FY2015ended Dec 31, 2015filed Feb 11, 2016FY2014ended Dec 31, 2014filed Feb 12, 2015FY2013ended Dec 31, 2013filed Feb 13, 2014FY2012ended Dec 31, 2012filed May 14, 2013FY2011ended Dec 31, 2011filed May 14, 2013
Revenue16,31015,40514,98414,41013,87411,35911,08810,4129,7026,8155,7375,4605,1004,8664,328
Cost of revenue———————————————
Gross profit———————————————
Research and development——————————3651010
Selling, general and administrative1,9991,9922,0532,0711,9641,7891,7341,7161,6221,016815781861818762
Operating income2,1822,2021,9771,7991,393731777741665576646590462396345
Other income (expense)9990124(33)1306537(5)(13)11(2)804(9)
Pretax income1,5911,6691,4591,3631,128373352328294416539501323267185
Income tax2523011012601637211659(992)325159149969315
Net income1,3601,3731,3581,0919662791912591,27772387357227178242
Diluted EPS ($)7.847.497.295.724.951.430.961.245.740.473.082.721.771.512.05
Diluted shares (millions)174183186191195195200208223152126131128118118

Balance sheet

IQVIA Holdings Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 15, 2023FY2021ended Dec 31, 2021filed Feb 16, 2022FY2020ended Dec 31, 2020filed Feb 12, 2021FY2019ended Dec 31, 2019filed Feb 18, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Feb 16, 2018FY2016ended Dec 31, 2016filed Feb 16, 2017FY2015ended Dec 31, 2015filed Feb 11, 2016FY2014ended Dec 31, 2014filed Feb 12, 2015FY2013ended Dec 31, 2013filed Feb 13, 2014FY2012ended Dec 31, 2012filed May 14, 2013FY2011ended Dec 31, 2011filed May 14, 2013
Cash and equivalents1,9801,7021,3761,2161,3661,8148378919591,198977867777568516
Short-term investments161141120931118862474640—————
Total current assets6,2495,8295,5964,9814,7635,0904,1263,8743,5543,3372,4122,1461,9461,510—
Total assets29,94426,89926,68125,33724,68924,56423,25122,54922,85721,2083,9263,2963,0542,4992,323
Total current liabilities8,3386,9576,4915,5785,2414,5583,9453,5343,1562,7051,5941,4721,4821,309—
Long-term debt13,88412,83812,95512,59512,03412,38411,54510,90710,1227,1082,4192,2832,0352,366—
Total liabilities23,31420,83220,56919,57218,64718,28416,98815,59514,61312,3484,2624,0003,7343,858—
Stockholders’ equity6,5036,0676,1125,7656,0426,0016,0036,7147,9958,633(564)(704)(667)(1,360)—
Shares outstanding (millions)170176182186190191192198208236119124130——

Cash flow statement

IQVIA Holdings Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 13, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 15, 2023FY2021ended Dec 31, 2021filed Feb 16, 2022FY2020ended Dec 31, 2020filed Feb 12, 2021FY2019ended Dec 31, 2019filed Feb 18, 2020FY2018ended Dec 31, 2018filed Feb 19, 2019FY2017ended Dec 31, 2017filed Feb 16, 2018FY2016ended Dec 31, 2016filed Feb 16, 2017FY2015ended Dec 31, 2015filed Feb 11, 2016FY2014ended Dec 31, 2014filed Feb 12, 2015FY2013ended Dec 31, 2013filed Feb 13, 2014FY2012ended Dec 31, 2012filed May 14, 2013FY2011ended Dec 31, 2011filed May 14, 2013
Operating cash flow2,6542,7162,1492,2602,9421,9591,4171,254970860—————
Capital expenditures6036026496746406165824593691647883887176
Free cash flow (CFO − capex)2,0512,1141,5001,5862,3021,343835795601696—————
Depreciation and amortization1,1441,1141,1251,1301,2641,2871,2021,1411,0112891281211089892
Share repurchases1,2441,3509921,1684064479491,4052,6201,09751541561314
Dividends paid—————————————568288

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$2M
2 sales by 2 insiders; officers and directors $2M
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$38M
10 sales by 6 insiders; officers and directors $38M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Sep 2, 2026Berkshire James G.See Remarksoption exercise5,381$131.82$709K13,558Sep 4, 2026
Sep 2, 2026Berkshire James G.See Remarksopen-market sale2,668$261.33$697K10,890Sep 4, 2026
Sep 2, 2026Berkshire James G.See Remarksdisposition to issuer2,713$261.54$710K8,177Sep 4, 2026
Aug 3, 2026Staub W RichardSee Remarksopen-market sale5,500$232.68$1M13,312Aug 4, 2026
Jul 31, 2026Patel BhavikSee Remarksopen-market sale1,855$235.27$436K1,348Aug 4, 2026
Jul 29, 2026Sherbet EricSee Remarksopen-market sale5,000$249.16$1M20,999Jul 31, 2026
Jul 29, 2026Cherofsky KeriannSee Remarksopen-market sale558$245.21$137K2,989Jul 31, 2026
Jul 29, 2026Bousbib AriSee Remarks, Directoroption exercise156,206$78.21$12M992,147Jul 31, 2026
Jul 29, 2026Bousbib AriSee Remarks, Directoropen-market sale4,465$247.10$1M987,682Jul 31, 2026
Jul 29, 2026Bousbib AriSee Remarks, Directoropen-market sale4,584$246.85$1M983,098Jul 31, 2026
Jul 29, 2026Bousbib AriSee Remarks, Directoropen-market sale44,039$246.08$11M939,059Jul 31, 2026
Jul 29, 2026Bousbib AriSee Remarks, Directoropen-market sale53,191$244.78$13M885,868Jul 31, 2026
Jul 29, 2026Bousbib AriSee Remarks, Directordisposition to issuer47,858$244.60$12M838,010Jul 31, 2026
Jul 29, 2026Bousbib AriSee Remarks, Directordisposition to issuer2,069$247.00$511K835,941Jul 31, 2026
Apr 23, 2026Leonard John MDirectoraward1,571$0.00—16,946Apr 27, 2026
Apr 23, 2026Goggins Colleen ADirectoraward1,571$0.00—14,453Apr 27, 2026
Apr 23, 2026Danhakl John GDirectorawardindirect1,571$0.00—30,612Apr 27, 2026
Apr 23, 2026Burt CarolDirectorawardindirect1,571$0.00—7,533Apr 27, 2026
Feb 13, 2026Haas BerndSee Remarkstax withholding20$166.94$3K24,394Feb 17, 2026
Feb 13, 2026Fedock Michael J.See Remarkstax withholding123$166.94$21K9,472Feb 17, 2026
Feb 8, 2026Haas BerndSee Remarkstax withholding440$187.49$82K24,414Feb 10, 2026
Feb 8, 2026Haas BerndSee Remarksaward8,265$0.00—24,854Feb 10, 2026
Feb 8, 2026Grenfell AlistairSee Remarkstax withholding5,545$187.49$1M24,124Feb 10, 2026
Feb 8, 2026Grenfell AlistairSee Remarksaward11,795$0.00—29,669Feb 10, 2026
Feb 8, 2026Fedock Michael J.See Remarkstax withholding2,420$187.49$454K9,595Feb 10, 2026

Full insider history for IQVIA Holdings Inc., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
IQVIA HOLDINGS INC., CIK 1478242 on EDGAR
Extract generated
October 28, 2026
Withheld
2 line-years whose four quarters do not sum to the filed year: net income FY2016, operating income FY2016
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2022
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues
Cost of revenue: CostOfRevenue
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent, ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated October 28, 2026.

JSON file
/data/financials/IQV.json